Cite

HARVARD Citation

    Chhatwal, J. et al. (2021). A phase 4 study of the safety of the 13-valent pneumococcal conjugate vaccine in children 6 to 17 years of age in India. Vaccine. 39 (37), pp. 5313-5317. [Online]. 
  
Back to record